Stockscreener 앱 받기
7.83
2.76%
0.21
전일 마감가:
$7.62
열려 있는:
$7.64
하루 거래량:
158.79K
Relative Volume:
0.53
시가총액:
$137.44M
수익:
$1.54M
순이익/손실:
$-38.70M
주가수익비율:
-1.6767
EPS:
-4.67
순현금흐름:
$-36.86M
1주 성능:
+5.95%
1개월 성능:
-2.00%
6개월 성능:
-12.61%
1년 성능:
-13.19%
1일 변동 폭
$7.26
$7.90
1주일 범위
$7.26
$8.23
52주 변동 폭
$4.64
$20.56
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
명칭
Corbus Pharmaceuticals Holdings Inc
전화
617-963-0103
주소
500 RIVER RIDGE DRIVE, NORWOOD, MA
Compare CRBP vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRBP
Corbus Pharmaceuticals Holdings Inc
|
7.83 | 133.75M | 1.54M | -38.70M | -36.86M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-30 | 재개 | B. Riley Securities | Buy |
| 2025-02-28 | 개시 | William Blair | Outperform |
| 2024-12-02 | 개시 | Piper Sandler | Overweight |
| 2024-07-30 | 개시 | Wedbush | Outperform |
| 2024-07-22 | 재개 | H.C. Wainwright | Buy |
| 2024-06-26 | 개시 | B. Riley Securities | Buy |
| 2024-06-03 | 재확인 | Oppenheimer | Outperform |
| 2024-05-13 | 개시 | RBC Capital Mkts | Outperform |
| 2024-03-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-09-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-09-08 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-09-08 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-08 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2020-07-07 | 개시 | ROTH Capital | Buy |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2020-03-26 | 개시 | Nomura | Buy |
| 2019-04-05 | 개시 | Jefferies | Buy |
| 2019-03-20 | 개시 | Oppenheimer | Outperform |
| 2019-01-11 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-12-26 | 개시 | H.C. Wainwright | Buy |
| 2018-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2018-10-24 | 개시 | B. Riley FBR | Buy |
| 2018-01-19 | 개시 | Raymond James | Outperform |
| 2017-12-14 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-11-08 | 재확인 | Noble Financial | Buy |
| 2017-09-29 | 재개 | Noble Financial | Buy |
| 2017-03-30 | 재확인 | Cantor Fitzgerald | Overweight |
| 2016-11-15 | 재확인 | JMP Securities | Mkt Outperform |
| 2016-11-11 | 재확인 | Noble Financial | Buy |
모두보기
Corbus Pharmaceuticals Holdings Inc 주식(CRBP)의 최신 뉴스
Decliners Report: What is Corbus Pharmaceuticals Holdings Incs revenue forecastJuly 2025 Patterns & Low Drawdown Trading Techniques - baoquankhu1.vn
Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference - Bitget
Corbus Pharmaceuticals to Present at 36th Annual Oppenheimer Healthcare Life Sciences Conference - Quiver Quantitative
Stock Recap: What is the cash position of Corbus Pharmaceuticals Holdings IncQuarterly Profit Report & Verified Momentum Stock Alerts - baoquankhu1.vn
Corbus Pharmaceuticals announces retirement of board member Holmer - MSN
Published on: 2026-02-08 12:15:37 - baoquankhu1.vn
Responsive Playbooks and the CRBP Inflection - Stock Traders Daily
Corbus Pharmaceuticals: Maintaining 'Hold' As Summer 2026 Obesity Data Catalyst Looms - Seeking Alpha
Forecast Cut: What dividend growth rate does Corbus Pharmaceuticals Holdings Inc offerJuly 2025 Intraday Action & Weekly Setup with ROI Potential - baoquankhu1.vn
Corbus Pharmaceuticals (CRBP) Stock Price, News & Analysis - MarketBeat
Dominic Smethurst Sells 3,285 Shares of Corbus Pharmaceuticals (NASDAQ:CRBP) Stock - MarketBeat
Corbus Pharmaceuticals (NASDAQ:CRBP) COO Sells $19,537.35 in Stock - MarketBeat
Signal Recap: How is Corbus Pharmaceuticals Holdings Inc managing supply chain issues2025 Breakouts & Breakdowns & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Corbus Pharmaceuticals Completes $75 Million Public Offering - MSN
Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains - 富途牛牛
While institutions invested in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) benefited from last week's 12% gain, individual investors stood to gain the most - simplywall.st
Understanding the Setup: (CRBP) and Scalable Risk - Stock Traders Daily
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Aberdeen Group plc Expands Holdings in Corbus Pharmaceuticals Ho - GuruFocus
Can Corbus Pharmaceuticals Holdings Inc. stock sustain institutional interestLong Setup & Daily Price Action Insights - bollywoodhelpline.com
Revenue Check: How is Corbus Pharmaceuticals Holdings Inc managing supply chain issues2025 Geopolitical Influence & Accurate Intraday Trading Signals - baoquankhu1.vn
CRBP: CRB-701 and CRB-913 advance with strong data, regulatory clarity, and funding into 2028 - TradingView
Corbus Pharmaceuticals surges on CRB-913 trial success - Intellectia AI
Corbus declines following early-stage results on oral obesity asset CRB-913 - MSN
Market Wrap: Why Corbus Pharmaceuticals Holdings Inc stock could be next big winnerCPI Data & AI Enhanced Trading Signals - Bộ Nội Vụ
Corbus Updates Corporate Outlook, Highlights Diversified 2026 Pipeline - TipRanks
Published on: 2026-01-12 10:26:56 - Улправда
Corbus presents new cancer drug study at ASCO GU - MSN
Why Corbus Pharmaceuticals Holdings Inc. stock could outperform in 2025Gap Up & Weekly Top Performers Watchlists - Улправда
The 3 Best Cannabis Stocks to Buy for 2026 - Yahoo Finance
Will Corbus Pharmaceuticals Holdings Inc. stock continue upward momentumMarket Trend Review & Weekly Top Gainers Trade List - Улправда
Will Corbus Pharmaceuticals Holdings Inc. (3371) stock sustain dividend payoutsJuly 2025 Retail & Free Verified High Yield Trade Plans - Улправда
Aug Outlook: Will Corbus Pharmaceuticals Holdings Inc. stock continue upward momentum - Улправда
Corbus Pharmaceuticals (NASDAQ:CRBP) Share Price Crosses Below 50 Day Moving AverageHere's Why - MarketBeat
Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
News | postregister.comCorbus Pharmaceuticals Holdings, Inc.Common Stock (Nasdaq:CRBP) Detailed Stock Data - FinancialContent
Revenue per share of Corbus Pharmaceuticals Holdings Inc – LSE:0SZI - TradingView — Track All Markets
J.P. Morgan Healthcare Conference - marketscreener.com
Corbus Pharmaceuticals to Present Corporate Overview at the 2026 Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Corbus Pharmaceuticals shares rise on encouraging safety results for experimental obesity drug - MSN
While hedge funds own 24% of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), retail investors are its largest shareholders with 46% ownership - Yahoo Finance
Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
How Corbus Pharmaceuticals Holdings Inc. (CRBP) Affects Rotational Strategy Timing - Stock Traders Daily
Downgrade Watch: Will Corbus Pharmaceuticals Holdings Inc 3371 stock top growth indexesMarket Growth Summary & Daily Volume Surge Trade Alerts - Bộ Nội Vụ
Corbus Pharmaceuticals Holdings Inc (CRBP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.24%
0.19%
자본화:
|
볼륨(24시간):